For patients with pancreatic carcinoma, CXCL12 expression was reduced in tumor tissues, but significant levels were detected in paracancerous tissues, normal pancreas and lymph nodes. This evidence concerns the gene CXCL12 and exocrine pancreatic carcinoma.